Company intelligence / Profile preview

Metabolic Solutions

Nashua, New Hampshire, United Statesmetsol.com ↗

Ownership: Private
Development stage: Commercial

Overview

MSI provides stable isotope analysis services to pharmaceutical and academic researchers, including custom kit manufacturing, validated assays, GCLP measurements, breath tests for GI disorders, and mass spectrometry. They are CLIA certified and serve clients globally with a focus on metabolism-related studies. MSDC has developed small molecule therapeutics targeting mitochondrial dysfunction in metabolic diseases. Their lead compound(s) have completed Phase IIb trials in type II diabetes and are being explored for NASH as well as neurodegenerative diseases like Alzheimer's.

Therapeutic areas: GastroenterologyEndocrinologyNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Michael J. Fox Foundation funding/support noted

Beyond the preview

Go deeper on Metabolic Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metabolic Solutions.

Explore the full profile